UNICREDIT BANK/PUT/ABBVIE/150/0.1/18.09.24 Share Price

Warrant

DE000HD03JS1

Real-time BOERSE MUENCHEN 20:41:14 01/07/2024 BST
0.14 EUR +7.69% Intraday chart for UNICREDIT BANK/PUT/ABBVIE/150/0.1/18.09.24
Current month-63.89%
1 month-73.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/07/24 0.14 +7.69%
28/06/24 0.13 -13.33%
27/06/24 0.15 +15.38%
26/06/24 0.13 0.00%
25/06/24 0.13 0.00%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 08:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD03JS
ISINDE000HD03JS1
Date issued 23/10/2023
Strike 150 $
Maturity 18/09/2024 (79 Days)
Parity 10 : 1
Emission price 1.43
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.84
Lowest since issue 0.13
Delta-0.13x
Omega 15.42
Premium12.78x
Gearing117.47x
Moneyness 0.8807
Difference Strike -20.37 $
Difference Strike %-13.58%
Spread 0.01
Spread %7.14%
Theoretical value 0.1350
Implied Volatility 26.30 %
Total Loss Probability 84.04 %
Intrinsic value 0.000000
Present value 0.1350
Break even 148.55 €
Theta-0.02x
Vega0.02x
Rho-0x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
171.5 USD
Average target price
183.2 USD
Spread / Average Target
+6.83%
Consensus